glp 1 agonists long term effects Frontiers GLP-1 Agonists For Obesity In

Many patients experience substantial weight loss, with data from over 70,000 patients showing that individuals can lose up to 20% of their body mass after just six months of treatment

Tirzepatide (Mounjaro), which functions as both a GLP-1 and GIP receptor agonist, has demonstrated superior results in managing blood sugar and weight loss

M.BueterM.SmithK

Thus, many Americans have been exposed to the big names of GLP-1 drugs like Ozempic, Wegovy and Zepbound

First, GLP-1RA can activate the first messenger adenylate cyclase (AC) after binding to the receptor, which stimulates an increase in the secretion level of the intracellular second messenger cyclic adenosine phosphate (cAMP) and subsequently activates the intracellular secondary messenger protein kinase A (PKA) (48)

Moreover the implications for diabetic stability and obesity management are not trivial if the medication is ceased